Device-based remote monitoring decreases hospital service use by 72% when used to monitor patients requiring ongoing care.
Switching from beta-blockers to digoxin as first line therapy for older patients with AF could produce £100m in NHS savings annually.
Professor Martin Röcken discusses challenges and opportunities in dermatology care, immunotherapy, the MDT and his hopes for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback